Even though there have been no studies evaluating this approach, its something we definitely see in clinical practice. Who should consider microdosing GLP-1s
The test kit includes pre-paid shipping back to Nooms affiliated CLIA-certified lab for results within one week
Additional Resources Mercer: GLP-1 Considerations for 2026 Peterson-KFF: Employer Perspectives on GLP-1 Coverage Costs Blue Cross Blue Shield: How GLP-1s Could Increase Employer Premiums Morgan Lewis: GLP-1 Coverage, Obesity, and the ADA Related: ERISA Voluntary Benefits Compliance Checklist for Brokers (BenefitFlow) Sources for statistics cited in this article include SHRM, EBRI, HUB International, KFF, Mercer, Blue Cross Blue Shield Association, and the Business Group on Health
In France, the semaglutide 2.4-mg (Wegovy) was part of an early-access initiative from July 2022 to September 2023
Joe US 1 review Aug 4, 2025 Everyone has been extremely helpful